breast cancer Archives - TheJointBlog

Study: CBD May Be Useful In Treating Breast Cancer

July 16, 2018 by Anthony Martinelli

CBD may be a useful treatment for various breast cancer subtypes, according to a new study published by the journal The Breast.

“Studies have emphasized an antineoplastic effect of the non-psychoactive, phyto-cannabinoid, Cannabidiol (CBD)”, begins the study’s abstract, which was epublished ahead of print by the National Institute of Health. “However, the molecular mechanism underlying its antitumor activity is not fully elucidated. Herein, we have examined the effect of CBD on two different human breast cancer cell lines”.

In both cell lines, “CBD inhibited cell survival and induced apoptosis in a dose dependent manner as observed by MTT assay, morphological changes, DNA fragmentation and ELISA apoptosis assay.”

New Study: Cannabinoids a Promising Tool in Treatment of Breast and Prostate Cancer

September 19, 2016 by Anthony Martinelli

A new study being published in the upcoming issue of the journal Expert Opinion on Investigational Drugs, and published online ahead of print by the U.S. National Institute of Health, has found that cannabinoids may be a promising tool for the treatment of breast and prostate cancer.

According to the study’s abstract; “The aim of this review is to evaluate the promising chemotherapeutic utility of phytocannabinoids, endocannabinoids, and synthetic cannabinoids in breast and prostate cancer.”

In their evaluation, researchers found that; “Cannabinoids, in particular the non-psychoactive CBD, may be promising tools in combination therapy for breast and prostate cancer, due to their direct antitumor effects, their ability to improve the efficacy of conventional antitumor drugs and their usefulness as palliative treatment.”

Study: Cannabidiolic Acid (CBDA) Inhibits Highly Aggressive Breast Cancer

August 20, 2016August 18, 2016 by Anthony Martinelli

Cannabidiolic acid (CBDA), a little-known compound found in cannabis, can inhibit the migration of highly aggressive breast cancer, according to a study published by the Journal of Natural Medicines and published online by the National Institute of Health.

“The biological activities of CBDA have been attracting increasing attention”, states the study’s researchers, who “identified CBDA as an inhibitor of the migration of MDA-MB-231 cells, a widely used human breast cancer cell line in cancer biology, due to its highly aggressive nature.”

New Study Finds Cannabidiol Inhibits Growth of Highly Aggressive Breast Cancer

February 25, 2015February 12, 2015 by Anthony Martinelli

A new study published in the journal Molecular Oncology, and published online by the National Institute of Health, has found that the cannabis compound cannabidiol inhibits the growth and metastasis of highly aggressive breast cancer.

“The anti-tumor role and mechanisms of Cannabidiol (CBD), a non-psychotropic cannabinoid compound, are not well studied especially in triple-negative breast cancer (TNBC)”, says the study’s researchers. “In the present study, we analyzed CBD’s anti-tumorigenic activity against highly aggressive breast cancer cell lines including TNBC subtype.”

New Study Finds Cannabinoids Can Combat Breast Cancer

August 22, 2014June 14, 2014 by Anthony Martinelli

A nearly 10-year long study conducted by researchers at California Pacific Medical Center’s Research Institute, and published this month by the British Journal of Pharmacology, has found that cannabinoids can combat breast cancer progression.

“The psychoactive cannabinoid Δ⁹ -tetrahydrocannabinol (THC) and the non-psychoactive cannabinoid cannabidiol (CBD) can both reduce cancer progression each through distinct antitumor pathways”, begins the study’s abstract. “Our goal was to discover a compound that could efficiently target both cannabinoid antitumor pathways.”

New Study: CBD Can Protect Breast Cancer Patients From Chemotherapy-Induced Side Effects

November 22, 2013November 20, 2013 by Anthony Martinelli

A new study published by the British Journal of Pharmacology has found that not only can CBD (cannabidiol, a cannabis compound) protect breast cancer patients against neurotoxicity and pain associated with chemotherapy drugs, it can actually increase the cancer-fighting capabilities of these drugs.

According to researchers; “Paclitaxel (PAC) is associated with a chemotherapy-induced neuropathic pain (CIPN) state that can lead to the cessation of treatment in late stage breast cancer patients, even in the absence of alternate therapies.’ They state that; “Indeed, to date no one drug or drug class is considered to be effective for reversal of CIPN.”